Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 271 - 275 out of 316
Pleban, K, Hoffer, C, Kopp, S, Peer, M, Chiba, P & Ecker, G 2004, 'Intramolecular distribution of hydrophobicity influences pharmacological activity of propafenone-type MDR modulators', Archiv der Pharmazie, vol. 337, no. 6, pp. 328-334. https://doi.org/10.1002/ardp.200300862
Langer, T, Eder, M, Hoffmann, RD, Chiba, P & Ecker, G 2004, 'Lead identification for modulators of multidrug resistance based on in silico screening with a pharmacophoric feature model', Archiv der Pharmazie, vol. 337, no. 6, pp. 317-327. <http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-4043109757&partner@&rel=R5.0.4>
Lachmann, B, Noe, C, Ecker, G & Linz, B 2004, 'Permeation studies of a set of anthistamines with an in vitro blood-brain barrier model', European Journal of Pharmaceutical Sciences, vol. 23, no. Suppl 1, pp. S60.
Murias, M, Handler, N, Erker, T, Pleban, K, Ecker, G, Saiko, P, Szekeres, T & Jäger, W 2004, 'Resveratrol analogues as selective cyclooxygenase-2 inhibitors: Synthesis and structure-activity relationship', Bioorganic & Medicinal Chemistry, vol. 12, no. 21, pp. 5571-5578. <http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TF8-4D98TN3-2&_user=464575&_coverDate=11%2F01%2F2004&_rdoc=13&_fmt=summary&_orig=browse&_srch=doc-info(%23toc%235220%232004%23999879978%23522362%23FLA%23display%23Volume)&_cdi=5220&_sort=d&_docanchor=&_ct=27&_acct=C000022258&_version=1&_urlVersion=0&_userid=464575&md5=b168a2e8dd1519621f783878ddb1895d>
Klein, C, Kaiser, D & Ecker, G 2004, 'Topological Distance Based 3D Descriptors for Use in QSAR and Diversity Analysis', Journal of Chemical Information and Computer Sciences, vol. 44, no. 1, pp. 200-209. https://doi.org/10.1021/ci0256236
Activities
Showing entries 1 - 5 out of 207
AI in Drug Discovery and Toxicity Prediction
Gerhard Ecker
ARUA 2025
Conference,
Talk or oral contribution
30.10.2025 - 30.10.2025
In silico MIE Prediction
Gerhard Ecker
RISK-HUNT3R Stakeholder Symposium
Conference,
Talk or oral contribution
18.6.2025 - 18.6.2025
Prediction of Toxicity
Gerhard Ecker
CCC-Trio 2025
Conference,
Talk or oral contribution
12.6.2025 - 12.6.2025
Prediction of Toxicity - let's use Fingerprints
Gerhard Ecker
OpenTox Virtual Conference 2024
Conference,
Talk or oral contribution
29.11.2024 - 29.11.2024
In silica prediction of toxicity - from QSAR models to biological fingerprinting
Gerhard Ecker
AAPR 23 - patterns in one health
Conference,
Talk or oral contribution
25.10.2023 - 25.10.2023